The Diagnostic Workflow: From Symptom to Biopsy
The hallmark symptom of endometrial cancer in 2026 remains abnormal uterine bleeding, particularly in postmenopausal women.
The diagnostic journey typically begins with a transvaginal ultrasound to measure the thickness of the endometrial lining. If the lining appears thickened or irregular, a gold-standard endometrial biopsy or a D&C (dilation and curettage) is performed. Modern diagnostic clinics in 2026 now utilize office-based hysteroscopy, where a thin, lighted camera is inserted into the uterus, allowing the physician to visually identify and sample suspicious areas directly. This ensures higher diagnostic accuracy compared to "blind" biopsies, reducing the need for repeat procedures and accelerating the path to treatment.
